N, L., R, X., R, H., B, L., B, W., & Q, G. (2021). Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press.
Style de citation Chicago (17e éd.)N, Li, Xiong R, He R, Liu B, Wang B, et Geng Q. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)N, Li, et al. Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.